Why Glooko’s FDA-cleared EndoTool IV Cloud could reshape hospital glycemic management
Insulin dosing is moving to the cloud. Glooko’s FDA clearance raises bigger questions on hospital workflow, safety, and scale.
Why Glucotrack’s CBGM filing could test the next frontier in diabetes monitoring
Wearable CGMs dominate diabetes care. Glucotrack’s implantable CBGM now faces the harder FDA test: durable blood-based proof.
Medtronic’s MiniMed Go cleared by FDA: Can smart MDI finally close the algorithm gap in diabetes care?
Medtronic’s MiniMed Go earns FDA clearance. Learn how it could reshape insulin injection therapy by combining smart pens, CGM insights, and dose algorithms.
Can Medtronic and Abbott redefine insulin delivery with the Instinct-integrated MiniMed 780G?
Medtronic’s MiniMed 780G now ships in the U.S. with Abbott’s Instinct sensor. Explore how this launch could reshape CGM-insulin system competition.